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AbstrAct
In recent years, the evolution of healthcare challenged 
the management of people with rheumatic and 
musculoskeletal diseases (RMDs). From disease-centred 
care to person-focused care, a holistic approach along 
with patient empowerment about their disease, improved 
the physician-patient relationship and allowed to achieve 
better outcomes with lower healthcare costs. Nevertheless, 
RMDs may occur from childhood to the old age and to date 
very few studies have addressed the needs and priorities 
of young people with RMDs. However, the image of RMDs 
is still associated with the elderly population. In this regard, 
the group of young people with arthritis and rheumatism 
in Europe (PARE) was recently developed within European 
League Against Rheumatism to represent the voice of 
the young affected and to carry out projects aiming for 
a better understanding of these specific aspects. This 
viewpoint discusses the needs and priorities of young 
people compared with adult people with RMDs, based 
on the available literature and on the results of the PARE 
Youth research project, aiming to identify the next steps 
of actions that need to be taken to improve the current 
situation.
IntroductIon
Over the last decade, the attention of the 
scientific community dealing with rheumatic 
and musculoskeletal diseases (RMDs) has 
been drawn on the importance of incorpo-
rating the patient’s perspective in disease-re-
lated decisions.1 The active engagement of 
patients, their education about their disease, 
their empowerment aimed at optimising 
self-management, eventually leads to better 
clinical outcomes and reduction of health-
care costs.2 The European League Against 
Rheumatism (EULAR) has fully embraced 
the importance of involving patients since 
the European organisation of people with 
arthritis/rheumatism (PARE) constitutes one 
of the three pillars of EULAR (www. eular. 
org).3 4 Although patient empowerment is 
an important step towards the optimisation 
of patient management, a crucial issue is 
the impact of the patient’s age. RMDs may 
occur from childhood through to old age 
but to date very few studies have addressed 
the needs and priorities of young people with 
RMDs and there is no agreement across Euro-
pean countries on the definition of a ‘young 
patient’. To date, published data concerning 
the specific needs of young people with RMDs 
are lacking as studies specifically addressing 
this topic are very few. Furthermore, it has 
never been explored whether the needs and 
priorities of young people with RMDs who 
were diagnosed in paediatric age and those 
who were diagnosed between 18 and 35 years 
of age differ. Over the last few years, PARE 
has been working towards making the voice 
of young patients heard and this led to the 
birth of a working group called Young PARE.5 
Young PARE consists of people aged 18–35 
years affected by RMDs (either diagnosed 
within this age range or in paediatric age). In 
parallel, the PARE Youth research project was 
developed to gather a large amount of infor-
mation about youth organisations in EULAR 
countries and explore the views, needs 
and priorities of young people with RMDs 
through a mapping exercise and a Europe-
an-wide survey.6
In fact, only through understanding the 
similarities and differences of how RMDs 
impact on the life of young people compared 
with adult people it is possible to tailor and 
individualise the management of the disease 
in this subgroup of patients. The objective 
of this viewpoint is to discuss the needs and 
priorities of young people compared with 
adult people with RMDs, based on a literature 
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review and the results of the PARE Youth research project 
and identify actions to be taken to improve the current 
situation.
How rMds and tHeIr treatMent IMpact tHe lIves of 
young people?
For a better understanding on how the findings were 
gathered by the PARE Youth project, we introduce its 
structure: the mapping exercise aimed at exploring the 
organisation of youth groups in European countries, the 
qualitative interviews and focus groups aimed at under-
standing the life domains most affected in young people 
with RMDs. Based on this, a survey was developed and 
distributed among young patients in European countries. 
The data of 2329 respondents, aged 18–35 years, affected 
by at least one RMD, were analysed. Box 1 includes repre-
sentative sentences related to the different domains 
collected from patients during the qualitative study.
social and sexual life, mental health
A major concern of young people with RMDs is that 
they will not be accepted as full members of the society.6 
This feeling results from the fear of not being able to 
achieve set goals or keep control of their lives due to the 
unforeseeable evolution of the disease. Pain and fatigue 
represent the main obstacles in daily life, particularly 
for work ability and participation in social activities.6 
Besides these, one issue that infrequently assessed in 
clinical care when dealing with either adult or young 
patients is the impact of RMDs on sexual life. In both 
groups, about 70%–80% of subjects report having prob-
lems due to their condition, whereby womens’ sexual 
life is more affected than that of men.6 7 In this regard, 
the main concerns raised by young patients are pain/
discomfort, fatigue, lack of sexual interest or desire and 
perceptions of their body being unattractive.6 Conversely, 
in adult patients the impairment of mental health is the 
main determinant of sexual dysfunction and interestingly 
other physiological factors that affect sexual function in 
the general adult population such as obesity, history of 
cardiovascular events, smoking and alcohol consumption 
do not play any additional role in people with RMDs.7 8 
The shortcoming of information on pregnancy and espe-
cially on postnatal care further increases the fear of 
young women about having a successful pregnancy or 
being good mothers due to their disease.9 In this regard, 
a milestone has been set by the recent release of the first 
EULAR recommendations on women’s health for the 
management of family planning, assisted reproduction, 
pregnancy and menopause in patients with systemic 
lupus erythematosus and antiphospholipid syndrome.10 
These recommendations aim at providing the best care 
and appropriate counselling during the entire life span 
of females with this disease.
The PARE Youth report highlighted another remark-
able discrepancy, namely that >90% of patients reported 
that their RMD had an impact also on their mental health, 
but only 17% of them sought psychological support. Data 
from adult patients reveal that only about 30%–60% 
of subjects report that the disease affects their mental 
health,7 11 12 which further suggests that the burden of 
psychological impact of RMDs is more pronounced in 
young patients, necessitating prompt intervention. Living 
‘a normal life’ has the highest priority for young people 
and the prescription of therapy as well as even minor 
modifications of the ongoing therapy can cause anxiety 
in young people if they are not fully aware of short-term 
and long-term effects of treatment.13 In this regard, it is 
necessary to provide patients with all relevant informa-
tion about the implications and possible consequences 
of taking or not taking their treatment, in order to maxi-
mise treatment adherence, and offer them the opportu-
nity for discussion at every consultation.14
transition from the paediatric to the adult age
Optimal medication use lies in acknowledging the roles 
of personal and social identities, especially including the 
identity transformation, before the diagnosis to develop 
a new social identity after diagnosis. Such new identity 
is itself subject to changes over time as for instance in 
the transition phase from the paediatric to the adult 
healthcare system. The ‘significant others’, mainly 
mothers, play an important role in this process, whereby 
parents and young patients often show discrepant prior-
ities.14–16 Ideally, the transition should be a purposeful, 
organised and coordinated process involving the young, 
their family and the healthcare team, with the goal of 
box 1 examples of responses  from the pare youth 
research project
 ► I don’t know if it is possible to 100% accept that it is happening 
to me. 
 ► I am mentally trying to get used to the idea that things might go 
differently of what I expected for the rest of my life.
 ► In itself, the care from the hospital is good, but mainly focused on 
drugs. They take study or social life not really into account.
 ► Some people find it very frustrating if they cannot go to every 
party, I'm lucky if I can go to one.
 ► I got pregnant, but the doctor did not tell me that with my 
medication it is not allowed and I did not know to ask. I lost this 
chance.
 ► My first son was born deaf and my in-laws blamed my 
pharmacological treatment for their grandson’s disability. I was 
deeply hurt by this and felt very guilty for a long time even though 
I stopped all medication three months prior to his conception.
 ► In university some professors did not not believe [that I was sick] 
and said that young people don’t have this kind of disease.
 ► I noticed at first that colleagues said things behind my back, for 
example if I called in sick.
 ► The feeling of doubt that you get from other people—teachers, 
friends, doctors, is a big barrier that can make you cautious and 
closed.
 ► when I talk to other people, they only react how horrible it is. It is 
very different who you talk about it. In the (patient) association I 
understand them and they understand me.
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optimising health, preventing morbidity and facilitating 
personal development. However, data from a recent 
European-wide survey among paediatric rheumatolo-
gists pointed out that currently one in two up to half of 
young subjects do not experience a successful transfer 
to adult rheumatology, which exposes them to unfavour-
able outcomes.17 18 Many barriers for an effective and 
high-quality transition process have been identified with 
the most important being the assumption that transi-
tion merely means transferring the young person from 
a physician to another without any empowerment of 
the patient or their family.19 From the patient’s point of 
view, a large metasynthesis study, of all relevant studies 
enrolling young people with chronic diseases including 
RMDs, revealed that the transition phase is perceived 
from patients like being ‘in limbo’ between different 
cultures. The change in significant relationships, the 
transition to a new and unknown environment, the 
readiness to change independently of age and the shift 
of disease ‘ownership’ to the young person were identi-
fied as the four main themes in this transition process.20 
We observe with delight that this process of transition 
is becoming increasingly recognised as an important 
area for clinicians, researchers and policy makers to 
address.21
EULAR Young PARE is actively working to overcome 
these barriers and to ensure that patient associations 
are an active part of the transition process, providing 
patients in paediatric age all the support needed in this 
phase and ensuring their engagement within youth 
associations. In fact, it is recognised that the process of 
patient empowerment for the transition phase should 
start as early as possible to make sure that young people 
are ready when it comes to the actual transition into 
adult care. In this regard, a pioneering initiative to be 
used across specialties and applied to patients aged 
11+ with a long-term condition was developed by the 
National Health Service in the UK. The ‘Ready Steady 
Go’ initiative is based on the use of questionnaires 
covering different aspects relating to the disease and 
the transition phase; it starts at 11 years of age and ends 
after the first consultation in the adult care system. By 
the end of the ‘Go’ stage, the young people should have 
the confidence and ability to undertake the whole clinic 
consultation on their own.19
In addition, EULAR and the Paediatric Rheumatology 
European Society recently developed the standards and 
recommendations for the transition of young people 
with RMDs diagnosed in paediatric age.22 Although these 
recommendations set another milestone in the health-
care of young people with RMDs, the authors themselves 
acknowledge the objective difficulty in implementing 
them in clinical practice across different countries. 
Furthermore, several questions remain pending and the 
research agenda for the future includes a number of 
points to address, including the importance of outcome 
measures and predictors of successful transition.22
study and work ability
In terms of education and work ability, RMDs cause 
either delay or fewer opportunities in the school career 
and may be a major reason to quit a paid job. There is 
not enough understanding and awareness on this issue 
among teachers, educationalists and employers. In addi-
tion, the consistent heterogeneity of social policies for 
patient advocacy in different countries raises the issue of 
lack of uniform guidelines at European level to ensure 
harmonisation of patient care across countries. If the 
social environment of people with RMDs is not appropri-
ately informed about the disease, the interaction between 
the sick student and the teachers/schoolmates is heavily 
affected and the course of study is slowed down.23 In a 
working environment, young people as well as adult 
people with RMDs fear that employers might think that 
they are not able to accomplish the same as healthy 
coworkers. This is mirrored by the reluctance to reveal 
their condition during interviews for a new job and not 
even after being hired.6 24 However, it is often necessary 
to disclose the disease to explain frequent absences from 
work, although this remains uneasy for patients of any 
age.
Patient organisations, aside from providing supportive 
environments for patients, have proved to be a useful 
resource of information, advice and education about 
self-management of the disease. They play a crucial role 
in helping people to better understand and cope with 
their RMDs, for example, providing virtual communities 
and access to social media.25 The engagement of patients 
on social media platforms as well as increasing availability 
of dedicated medical mobile applications is particularly 
useful for young people who are more familiar and confi-
dent with this kind of ‘cyber-world’. Self-monitoring 
of the disease on a regular basis, easy access to health-
care-related reliable information as well as contact with 
people of the same age affected with RMDs supports 
young patients in better understanding their condition, 
enabling interaction between them and encouraging 
communication and sharing of experiences. This is also 
valuable in reducing isolation and silent suffering poten-
tially resulting in poor psychological consequences. 
Within patient organisations, the recognition that young 
people with RMDs have different needs and priorities 
compared with adults, resulted in the development of 
young patient organisations. Such an example at an 
international level is the EULAR Young PARE raised 
within the EULAR Standing Committee of PARE, which 
represents 36 European national patient organisations. 
The EULAR Young PARE group aims to improve the 
quality of life of young people with RMDs by raising the 
profile of these conditions, and by creating a network of 
individuals who work in European countries on behalf of 
young people with RMDs.5 Beyond that, patient organ-
isations play an increasingly prominent role also in the 
conduction of research. In modern rheumatology prac-
tice, providing links/contact with patient organisations 
along with a multidisciplinary team input (including the 
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physician, healthcare practitioner(s) and carers/family) 
represents an integral part of patient management.
tHe pHysIcIan-patIent relatIonsHIp In 2017
The engagement of young patients in disease-related 
decisions implies that the relationship with the physician 
is based on mutual trust and that patients are informed 
and educated about their disease. This would not be 
possible without the evolution and revolution that took 
place over the last few years in healthcare with regard to 
patient engagement in the development of recommen-
dations for disease management,11 26 patient empow-
erment for disease-related decisions1 and access to 
e-health resources.27 The doctor-patient relationship has 
evolved over time from the paternalistic approach char-
acterising the disease-centred care to the equality of the 
patient-centred care and person-focused care where the 
role of patients has shifted from being passive recipients 
to active participants responsible for the management 
of their disease.28 In fact, the pillar of patient-centred 
and person-focused care is a shared approach in deci-
sion making, where clinicians and patients jointly and 
actively participate in health decisions after discussing 
the options, benefits and harms, while considering the 
patient’s values, preferences and circumstances. The 
holistic approach of person-focused care mainly aims at 
targeting the illness, as defined by the unique experi-
ence of being unwell rather than the disease as defined 
by the mere pathophysiological process. Therefore, 
person-focused care also takes the age of patients at 
disease onset into account, to recognise different needs 
and priorities and it acknowledges that young patients 
are part of a familiar/personal network that should be 
integrated rather than replaced by the clinical network 
(physicians and health professionals). In this setting, 
a key event was the introduction of patient-reported 
outcomes (PROs) in research and clinical practice. 
PROs represent an essential tool to monitor the impact 
of the disease on quality of life and to further reach 
mutual treatment decisions between patients and physi-
cians.29 30 However, patients still use tools developed by 
physicians to report on their conditions and the scores 
again are evaluated by physicians, who further decide 
about the implications and consequences.31 32 In addi-
tion, several studies clearly demonstrate that the physi-
cians’ and patients’ perspectives on disease activity 
differ.33 34 One of the most frequently reported PROs, 
the patient global assessment (PtGA) deviates in many 
cases significantly from the evaluator global assessment 
(EGA).35–37 Pain seems to be the strongest determi-
nant of the PtGA and the number of swollen joints, of 
the EGA. These discrepancies between physician and 
patient assessment have perhaps the greatest impact on 
the treatment and evaluation of outcomes. In addition, 
currently available PROs like the Health Assessment 
Questionnaire or the Short Form 36 may not capture all 
that matters to patients, particularly for those younger 
at age, since their perspective on currently used PROs 
has not been explored.
future perspectIves and concludIng reMarks
Several forward steps have been made to develop a trustful 
and equal relationship between patients and physicians 
but it must be recognised that still many of the needs of 
young people with RMDs remain unmet. We acknowl-
edge that additional studies aimed at exploring the views, 
perspectives and needs of young people with RMDs will 
shed additional light on this topic and provide the basis 
to tailor healthcare strategies accordingly. As far as daily 
clinical practice is concerned, our first recommendation 
for physicians is to always ask patients about the impact of 
their disease on them and their life rather than trying to 
guess their thoughts; to carefully listen to them and try to 
understand different perspectives according to their age, 
taking this into account in any disease-related decisions 
made. Additionally, physicians should always aim to set 
up a pleasant and informal environment during consulta-
tion, where patients feel comfortable to discuss and raise 
any concerns—also on very personal topics— they might 
have. Physicians should provide patients with any infor-
mation they need to take decisions and to make sure that 
although significant others (eg, relatives, partners) tend 
to be prominent during consultation, the opinion of the 
young patient is always taken into account. Communica-
tion between physicians and patients in between consulta-
tions should be encouraged to strengthen their relation-
ship over time. However, any contact through interactive 
media is an option to be considered but should always be 
used conscientiously, balancing the readiness of such tools 
with the need of personal interaction and privacy issues. 
Finally, in the 19th century Sir William Osler already 
made the point that ‘the good physician treats the disease 
and the great physician treats the patient who has the 
disease’, but nowadays we believe that the best physician 
is the keystone of the clinical and familiar networks that 
manages the illness experienced by the patient over time. 
Looking into the future, we envisage that the increasing 
involvement of young patients in research projects, treat-
ment recommendations and specific PROs development 
and adaptations as well as the fostering of e-health are all 
important in bridging these gaps.
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